Fund Holdings — Nan Fung Group Holdings Ltd

Total Portfolio Value:
$63.43M
Total Bought:
$451.1K
Total Sold:
$61.94M
Net Transaction:
-$61.49M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Harmony Biosciences Holdings, Inc.(HRMY)368,665368,6650$12.24M$11.65M18.37%-$586.2K
Illumina, Inc.(ILMN)119,196119,1960$9.46M$11.37M17.93%+$1.92M
Oculis Holding AG(OCS)514,702514,7020$9.79M$9.99M15.75%+$195.6K
Incyte Corporation(INCY)59,02259,0220$3.57M$4.02M6.34%+$445.6K
BeOne Medicines AGADS(ONC)15,72215,7220$4.28M$3.81M6.00%-$473.2K
Madrigal Pharmaceuticals, Inc.(MDGL)11,87211,8720$3.93M$3.59M5.66%-$339.4K
Recursion Pharmaceuticals, Inc.CL A(RXRX)664,610664,6100$3.52M$3.36M5.30%-$152.9K
Rhythm Pharmaceuticals, Inc.(RYTM)49,12049,1200$2.60M$3.10M4.89%+$502.0K
Ascendis Pharma A/SADR(ASND)13,60013,6000$2.12M$2.35M3.70%+$227.7K
Standard BioTools Inc.(LAB)1,883,1791,883,1790$2.03M$2.26M3.56%+$226.0K
Acadia Pharmaceuticals Inc102,984102,9840$1.71M$2.22M3.50%+$510.8K
argenx SEADR(ARGX)2,8002,8000$1.66M$1.54M2.43%-$113.8K
Kymera Therapeutics, Inc.(KYMR)30,87530,8750$845.0K$1.35M2.12%+$502.3K
Revolution Medicines, Inc.(RVMD)19,25319,2530$680.8K$708.3K1.12%+$27.5K
Replimune Group, Inc.(REPL)414,24663,719-350,527$4.04M$592.0K0.93%-$3.45M
Bicycle Therapeutics PlcADS68,94368,9430$585.3K$479.2K0.76%-$106.2K
Bolt Biotherapeutics Inc058,347+58,347$0$336.7K0.53%+$336.7K
Entrada Therapeutics, Inc.(TRDA)49,08249,0820$443.7K$329.8K0.52%-$113.9K
Rani Therapeutics Holdings, Inc.CL A(RANI)493,584493,5840$621.9K$253.7K0.40%-$368.3K
Bolt Projs Hldgs Inc040,597+40,597$0$114.5K0.18%+$114.5K
Affimed N V37,2470-37,247$26.9K$0—-$26.9K
ALX Oncology Holdings Inc.(ALXO)41,9500-41,950$26.1K$0—-$26.1K
Bolt Biotherapeutics Inc1,166,9520-1,166,952$466.8K$0—-$466.8K
Bolt Projs Hldgs Inc811,9520-811,952$249.5K$0—-$249.5K
Climb Bio, Inc.(CLYM)463,6540-463,654$565.7K$0—-$565.7K
DBV Technologies S.A.ADS(DBVT)37,0950-37,095$253.0K$0—-$253.0K
Exelixis, Inc.(EXEL)64,2000-64,200$2.37M$0—-$2.37M
Geron Corporation(GERN)1,373,5500-1,373,550$2.18M$0—-$2.18M
Kalvista Pharmaceuticals Inc154,5220-154,522$1.78M$0—-$1.78M
Merus N V120,0380-120,038$5.05M$0—-$5.05M
Mirum Pharmaceuticals, Inc.(MIRM)146,7650-146,765$6.61M$0—-$6.61M
Protagonist Therapeutics Inc121,4000-121,400$5.87M$0—-$5.87M
Soleno Therapeutics Inc79,6500-79,650$5.69M$0—-$5.69M
Tourmaline Bio Inc227,0900-227,090$3.45M$0—-$3.45M
Verona Pharma PlcADS147,9900-147,990$9.40M$0—-$9.40M
Xenon Pharmaceuticals Inc.(XENE)158,6050-158,605$5.32M$0—-$5.32M
Zai Lab LimitedADR(ZLAB)253,6750-253,675$9.17M$0—-$9.17M
Page 1 of 1
Nan Fung Group Holdings Ltd — 13F Holdings — Q2 2025 | TickerTrail